                         SEQUENCE LISTING

<110>  ROGCON, INC.
 
<120>  ANTISENSE OLIGONUCLEOTIDES TARGETING SCN2A FOR THE TREATMENT OF 
       SCN1A ENCEPHALOPATHIES

<130>  51292-006WO2

<140>  PCT/US19/47313
<141>  2019-08-20

<150>  US 62/765,344
<151>  2018-08-20

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1
aaagctaaga gaccca                                                       16


<210>  2
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2
agattgcatt ttcacc                                                       16


<210>  3
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3
ggcaatactt cccaac                                                       16


<210>  4
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4
tgggtctctt agcttt                                                       16


<210>  5
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5
ggtgaaaatg caatct                                                       16


<210>  6
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6
gttgggaagt attgcc                                                       16


<210>  7
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7
tgctgtgcgg aaatctgcc                                                    19


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8
cggatgctca agagagactg g                                                 21


<210>  9
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9
gaggtgctgc tgatgtgc                                                     18


<210>  10
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10
ggcgttggga ttggtgact                                                    19


